Mauro Hanaoka, MD, CIIP, DABR
Radiology
Accepting new patients
Sees patients age 18 and up
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Radiology

Education and training

  • Medical School: University of Sao Paulo
  • Residency: Jersey Shore Medical Center
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Hanaoka is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Seyyed Ali Hosseini, Ghasem Hajianfar, Pardis Ghaffarian, Milad Seyfi, Elahe Hosseini, Atlas Haddadi Aval, Stijn Servaes, Mauro Hanaoka, Pedro Rosa-Neto, Sanjeev Chawla, Habib Zaidi, Mohammad Reza Ay PET radiomics-based lymphovascular invasion prediction in lung cancer using multiple segmentation and multi-machine learning algorithms , Phys Eng Sci Med , 47(4): 2024,1613-1625


Laiz Laura de Godoy, Kheng Choon Lim, Archith Rajan, Gaurav Verma, Mauro Hanaoka, Donald M O'Rourke, John Y K Lee, Arati Desai, Sanjeev Chawla, Suyash Mohan Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI , Cancers, 15(18): 2023,4453


Wang X, Shikoh F, Clark A, Hanaoka M. Avoidable and Unavoidable Repeat Breast Core Needle Biopsies. , Arch Breast Cancer, 9(1): 2022,32-39


Kapoor H, Hanaoka M, Dawkins A, Khurana A Review of MRI imaging for placenta accreta spectrum: Pathophysiologic insights, imaging signs, and recent developments , Placenta, 104: 2021,31-39


Aal AKA, Moawad S, Lune PV, El Khudari H, Hanaoka MM, Abouldahab N, Gunn AJ, White J, Shoreibah M, Li Y, Saddekni S, Mahmoud K Survival Outcomes of Very Small Drug-Eluting Beads Used in Chemoembolization of Unresectable Hepatocellular Carcinoma , Journal Vasc. Interv. Radiology, 30(9): 2019,1325-1334


Aal A, Moawad S, Jackson B, Hanaoka M, Baalmann C, Ertel N, Pettibon K, Harris A, Patel A, Lambertsen Z, Newman G, Saddekni S Tumor response and survival outcomes of very small drug-eluting beads used in transarterial chemoembolization for unresectable hepatocellular carcinoma , Journal of Vascular and Interventional Radiology., 28(2): 2017,S124–S125


Aal A, Shoreibah M, Kim S, Jackson B, Moawad S, Hanaoka M, Massoud M, Saddekni S Psoas muscle density predicts survival of cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt , Journal of Vascular and Interventional Radiology, 28(2): 2017,S168


Aal A, Moawad S, Hanaoka M, Jackson B, Abouarab A, Tatum T, Jacob R, Saddekni S. Adjuvant stereotactic body radiotherapy following transarterial chemoembolization using small diameter drug-eluting beads in patients with unresectable hepatocellular carci. Adjuvant stereotactic body radiotherapy following transarterial chemoembolization using small diameter drug eluting beads in patients with unresectable hepatocellular carcinoma tumors of equal or greater than 3 cm , Journal of Vascular and Interventional Radiology, 28(2): 2017,S80


Raghavan ML, Hanaoka MM, Kratzberg JA, Higuchi ML, da Silva ES Biomechanical failure properties and microstructural content of ruptured and unruptured abdominal aortic aneurysms , Journal of Biomechanics, 44(13): 2011,2501-2507


Hensley P, Goodwin, J, Dugan A, Hanaoka M, Bylund J, Harris A Analyzing patient-specific factors contributing to extend PACU length of stay and subsequent cost: a quality improvement initiative. . 2009, May; . , Journal of Urology, 201((Supplement 4)): 2009,e933